Clinical benefit of spironolactone in patients with acute decompensated heart failure and severe renal dysfunction: Data from the Korean Heart Failure Registry

American Heart Journal

Volumn 169, Issue 5, 2015, Pages 713-720.e3

  Oh, Jaewon ^a   Kang, Seok Min ^a   Song, Mi Kyung ^a   Hong, Namki ^a   Youn, Jong Chan ^a   Han, Seongwoo ^b   Jeon, Eun Seok ^c   Cho, Myeong Chan ^d   Kim, Jae Joong ^e   Yoo, Byung Su ^f   Chae, Shung Chull ^g   Oh, Byung Hee ^h   Choi, Dong Ju ⁱ   Lee, Myung Mook ^j   Ryu, Kyu Hyung ^b  

^a Yonsei University   (South Korea)

^b Hallym University   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Chungbuk National University Hospital   (South Korea)

^e University of Ulsan   (South Korea)

^f Yonsei University Wonju   (South Korea)

^g Kyungpook National University Hospital   (South Korea)

^h Seoul National University Hospital   (South Korea)

ⁱ Seoul National University Bundang Hospital   (South Korea)

^j Dongguk University Ilsan Hospital   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SODIUM; SPIRONOLACTONE; MINERALOCORTICOID ANTAGONIST;

ACUTE HEART FAILURE; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOFILTRATION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SEVERE RENAL IMPAIRMENT; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; ACUTE DISEASE; CLINICAL TRIAL; COMPLICATION; HEART FAILURE; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SPIRONOLACTONE;

EID: 84929280094     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.01.014     Document Type: Article

References (38)

1. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
2. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
3. F. Zannad, J.J. McMurray, and H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
4. F.A. Masoudi, E.P. Havranek, and P. Wolfe Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure Am Heart J 146 2003 250 257
5. A.F. Hernandez, X. Mi, and B.G. Hammill Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction JAMA 308 2012 2097 2107
6. L.H. Curtis, X. Mi, and L.G. Qualls Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure Am Heart J 165 2013 979 986
7. L.H. Lund, B. Svennblad, and H. Melhus Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study Circ Heart Fail 6 2013 174 183
8. O. Vardeny, D.H. Wu, and A. Desai Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study) J Am Coll Cardiol 60 2012 2082 2089
9. J. Butler, J.A. Ezekowitz, and S.P. Collins Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee J Card Fail 18 2012 265 281
10. C.W. Yancy, M. Jessup, and B. Bozkurt ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 2013 2013
11. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
12. B. Waldum, A.S. Westheim, and L. Sandvik Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry J Am Coll Cardiol 59 2012 371 378
13. D.J. Choi, S. Han, and E.S. Jeon Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure registry Korean Circ J 41 2011 363 371
14. J. Oh, S.M. Kang, and N. Hong The CKD-EPI is more accurate in clinical outcome prediction than MDRD equation in acute heart failure: data from the Korean Heart Failure (KorHF) Registry Int J Cardiol 167 2013 1084 1087
15. J. Oh, S.M. Kang, and N. Hong Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry Int J Cardiol 168 2013 4739 4743
16. S.J. Park, Y.K. On, and K. Byeon Short- and long-term outcomes depending on electrical dyssynchrony markers in patients presenting with acute heart failure: clinical implication of the first-degree atrioventricular block and QRS prolongation from the Korean Heart Failure registry Am Heart J 165 2013 57 64
17. J. Oh, S.M. Kang, and N. Hong Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure J Card Fail 15 2009 517 522
18. J. Oh, S.M. Kang, and H. Won Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients Circ J 76 2012 109 116
19. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
20. N. Girerd, J. Magne, and M. Rabilloud The impact of complete revascularization on long-term survival is strongly dependent on age Ann Thorac Surg 94 2012 1166 1172
21. P.A. Gum, M. Thamilarasan, and J. Watanabe Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis JAMA 286 2001 1187 1194
22. N. Abutaleb Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components Nephrol Dial Transplant 22 2007 2728 2729
23. A.N. Rassi, M.A. Cavender, and G.C. Fonarow Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction J Am Coll Cardiol 61 2013 35 40
24. R. Eschalier, J.J. McMurray, and K. Swedberg Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) J Am Coll Cardiol 62 2013 1585 1593
25. A. Gjesing, M. Schou, and C. Torp-Pedersen Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care Eur J Heart Fail 15 2013 671 678
26. J.M. Testani, T.P. Cappola, and C.M. Brensinger Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure J Am Coll Cardiol 58 2011 375 382
27. H.J. Lin, C.L. Chao, and K.L. Chien Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure Clin Res Cardiol 98 2009 487 492
28. J.M. Testani, S.G. Coca, and R.P. Shannon Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials Eur J Heart Fail 13 2011 1224 1230
29. M.A. Brisco, S.G. Coca, and J. Chen Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure Circ Heart Fail 6 2013 233 239
30. J.R. Teerlink, G. Cotter, and B.A. Davison Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
31. J.G. Cleland, J.R. Teerlink, and R. Senior The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial Lancet 378 2011 676 683
32. N. Girerd, P.S. Pang, and K. Swedberg Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial Eur J Heart Fail 15 2013 1228 1235
33. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
34. K. Patel, G.C. Fonarow, and D.W. Kitzman Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction JACC Heart Fail 1 2013 40 47
35. F. Edelmann, R. Wachter, and A.G. Schmidt Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
36. B. Pitt, M.A. Pfeffer, and S.F. Assmann Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392
37. J.P. Ferreira, M. Santos, and S. Almeida Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure Eur J Intern Med 25 2014 67 72
38. M. Yamaji, T. Tsutamoto, and C. Kawahara Effect of eplerenone versus spironolactone on cortisol and hemoglobin A(1)(c) levels in patients with chronic heart failure Am Heart J 160 2010 915 921